MAZE THERAPEUTICS, INC. Active Patents
4 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2024-03-26: Application 18617266; Invention APOL1 INHIBITORS AND METHODS OF USE; Applicant Maze Therapeutics, Inc.; Status Patented Case.
- 2023-09-08: Application 18243973; Invention INHIBITORS OF GLYCOGEN SYNTHASE 1 (GYS1) AND METHODS OF USE THEREOF; Applicant Maze Therapeutics, Inc.; Status Patented Case.
- 2023-01-17: Application 18098070; Invention APOL1 INHIBITORS AND METHODS OF USE; Applicant Maze Therapeutics, Inc.; Status Patented Case.
- 2022-03-14: Application 17694311; Invention INHIBITORS OF GLYCOGEN SYNTHASE 1 (GYS1) AND METHODS OF USE THEREOF; Applicant Maze Therapeutics, Inc.; Status Patented Case.
| Filed | Application | Invention | Applicant | Status | Granted | Patent | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-26 | 18617266 | APOL1 INHIBITORS AND METHODS OF USE | Maze Therapeutics, Inc. | Patented Case | 2025-07-01 | 12344610 | US20240400565A1 | Patrick Sang Tae LEE Todd Jonathan August EWING Adam Neil REID Christopher Joseph SINZ Birong ZHANG Sarah M. BRONNER David John MORGANS JR. Maarten HOEK Victoria Anne ASSIMON Chris ZIEBENHAUS Alexander Wayne SCHAMMEL | United States United States United States United States United States United States United States United States United States United States United States | AULAKH, CHARANJIT |
| 2023-09-08 | 18243973 | INHIBITORS OF GLYCOGEN SYNTHASE 1 (GYS1) AND METHODS OF USE THEREOF | Maze Therapeutics, Inc. | Patented Case | 2026-01-27 | 12534453 | US20240246939A1 | David John MORGANS JR. Kevin MELLEM Hannah L. POWERS Patrick Sang Tae LEE Walter WON Christopher Joseph SINZ | United States United States United States United States United States United States | RAO, PADMAJA S |
| 2023-01-17 | 18098070 | APOL1 INHIBITORS AND METHODS OF USE | Maze Therapeutics, Inc. | Patented Case | 2024-05-07 | 11976067 | US20230265096A1 | Patrick Sang Tae LEE Todd Jonathan August EWING Adam Neil REID Christopher Joseph SINZ Birong ZHANG Sarah M. BRONNER David John MORGANS Jr. Maarten HOEK Victoria Anne ASSIMON Chris ZIEBENHAUS Alexander Wayne SCHAMMEL | United States United States United States United States United States United States United States United States United States United States United States | AULAKH, CHARANJIT |
| 2022-03-14 | 17694311 | INHIBITORS OF GLYCOGEN SYNTHASE 1 (GYS1) AND METHODS OF USE THEREOF | Maze Therapeutics, Inc. | Patented Case | 2023-11-14 | 11814367 | US20230104740A1 | David John MORGANS JR. Kevin MELLEM Hannah L. POWERS Patrick Sang Tae LEE Walter WON Christopher Joseph SINZ | United States United States United States United States United States United States | RAO, PADMAJA S |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |